Federal Register / Vol. 89, No. 26 / Wednesday, February 7, 2024 / Notices 8439 

Exclusive Patent License should be 

directed to: Andrew Burke, Ph.D., 

Senior Technology Transfer Manager, 

NCI Technology Transfer Center, 

Telephone: (240)-276–5484; Email: 

andy.burke@nih.gov. 

SUPPLEMENTARY INFORMATION: 

Intellectual Property 

1. United States Provisional Patent 

Application No. 63/295,762 filed 

December 31, 2021, entitled ‘‘T Cell 

Therapy with Vaccination as a 

Combination Immunotherapy Against 

Cancer’’ [HHS Reference No. E–046– 

2022–0–US–01]; and 

2. International Patent Application 

No. PCT/US2022/082579 filed 

December 29, 2022, entitled ‘‘T Cell 

Therapy with Vaccination as a 

Combination Immunotherapy Against 

Cancer’’ [HHS Reference No. E–046– 

2022–0–PCT–02]. 

The patent rights in these inventions 

have been assigned and/or exclusively 

licensed to the government of the 

United States of America. 

The prospective exclusive license 

territory may be worldwide, and the 

field of use may be limited to the 

following: 

‘‘Development, manufacture, and 

commercialization of combination 

immunotherapies for the treatment of cancer 

in humans, comprising at least the following 

elements: 

1. An autologous T cell product, where the 

T cells are tumor infiltrating lymphocytes 

(TIL) or chimeric antigen receptor-expressing 

T cells (CAR–T); and 

2. A neoantigen cancer vaccine.’’ 

The E–046–2022 patent family is 

primarily directed to a combination 

immunotherapy comprising a 

population of antigen-specific immune 

cells (e.g., T cells) and a vaccine 

targeting the same antigen(s). In 

oncology, many investigational adoptive 

cell therapies rely on antigen-specific T 

cells isolated from the patient in need 

of treatment. However, these cells often 

exist in a terminally differentiated and 

exhausted state and are unable to mount 

a robust immune response following 

reinfusion. Recent evidence suggests 

that administration of a vaccine in 

parallel with the T cell product can 

ameliorate this performance defect 

when the vaccine targets antigen(s) 

recognized by the T cells. It is hoped 

that this two-part approach will 

enhance treatment efficacy. The 

exclusive field of use which may be 

granted to Marble applies to only certain 

autologous T cell products and 

vaccination strategies and does not 

include, for example, at least two broad 

classes of cell therapies: allogeneic T 

cell-based products and TCR-engineered 

T cell products (TCR–T). Accordingly, 

the proposed scope of rights which may 

be conveyed under the license covers a 

portion of the possible applications of 

E–046–2022. 

This Notice is made in accordance 

with 35 U.S.C. 209 and 37 CFR part 404. 

The prospective exclusive license will 

be royalty bearing, and the prospective 

exclusive license may be granted unless 

within fifteen (15) days from the date of 

this published Notice, the National 

Cancer Institute receives written 

evidence and argument that establishes 

that the grant of the license would not 

be consistent with the requirements of 

35 U.S.C. 209 and 37 CFR part 404. 

In response to this Notice, the public 

may file comments or objections. 

Comments and objections, other than 

those in the form of a license 

application, will not be treated 

confidentially and may be made 

publicly available. 

License applications submitted in 

response to this Notice will be 

presumed to contain business 

confidential information and any release 

of information from these license 

applications will be made only as 

required and upon a request under the 

Freedom of Information Act, 5 U.S.C. 

552. 

Dated: February 2, 2024. 

Richard U. Rodriguez, 

Associate Director, Technology Transfer 

Center, National Cancer Institute. 

[FR Doc. 2024–02491 Filed 2–6–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF THE INTERIOR 

Bureau of Indian Affairs 

[245A2100DD/AAKC001030/A0A50

1010.999900; OMB Control Number 1076– 

0188] 

Agency Information Collection 

Activities; Submission to the Office of 

Management and Budget for Review 

and Approval; Appraisals and 

Valuations of Indian Property 

AGENCY: Bureau of Indian Affairs, 

Interior. 

ACTION: Notice of information collection; 

request for comment. 

SUMMARY: In accordance with the 

Paperwork Reduction Act of 1995, we, 

the Bureau of Indian Affairs (BIA) are 

proposing to renew an information 

collection. 

DATES: Interested persons are invited to 

submit comments on or before March 8, 

2024. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection request (ICR) 

should be sent within 30 days of 

publication of this notice to the Office 

of Information and Regulatory Affairs 

(OIRA) through https://

www.reginfo.gov/public/do/PRA/

icrPublicCommentRequest?ref_

nbr=202212-1076-003 or by visiting 

https://www.reginfo.gov/public/do/PRA

Main and selecting ‘‘Currently under 

Review—Open for Public Comments’’ 

and then scrolling down to the 

‘‘Department of the Interior.’’ 

FOR FURTHER INFORMATION CONTACT: To 

request additional information about 

this ICR, contact Steven Mullen, 

Information Collection Clearance 

Officer, Office of Regulatory Affairs and 

Collaborative Action—Indian Affairs, 

U.S. Department of the Interior, 1001 

Indian School Road NW, Suite 229, 

Albuquerque, New Mexico 87104; 

comments@bia.gov; (202) 924–2650. 

Individuals in the United States who are 

deaf, deafblind, hard of hearing, or have 

a speech disability may dial 711 (TTY, 

TDD, or TeleBraille) to access 

telecommunications relay services. You 

may also view the ICR at https://

www.reginfo.gov/public/Forward?

SearchTarget=PRA&textfield=1076- 

0188. 

SUPPLEMENTARY INFORMATION: In 

accordance with the Paperwork 

Reduction Act of 1995 (PRA, 44 U.S.C. 

3501 et seq.) and 5 CFR 1320.8(d)(1), we 

provide the general public and other 

Federal agencies with an opportunity to 

comment on new, proposed, revised, 

and continuing collections of 

information. This helps us assess the 

impact of our information collection 

requirements and minimize the public’s 

reporting burden. It also helps the 

public understand our information 

collection requirements and provide the 

requested data in the desired format. 

A Federal Register notice with a 60- 

day public comment period soliciting 

comments on this collection of 

information was published on January 

5, 2023 (88 FR 879). No comments were 

received. 

As part of our continuing effort to 

reduce paperwork and respondent 

burdens, we are again soliciting 

comments from the public and other 

Federal agencies on the proposed ICR 

that is described below. We are 

especially interested in public comment 

addressing the following: 

(1) Whether or not the collection of 

information is necessary for the proper 

performance of the functions of the 

agency, including whether or not the 

information will have practical utility; 


khammond on DSKJM1Z7X2PROD with NOTICES
8440 Federal Register / Vol. 89, No. 26 / Wednesday, February 7, 2024 / Notices 

1The record is defined in § 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

1The record is defined in § 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

2 88 FR 87407 (December 18, 2023). 

3Chairman David S. Johanson dissenting. 

(2) The accuracy of our estimate of the 

burden for this collection of 

information, including the validity of 

the methodology and assumptions used; 

(3) Ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and 

(4) How might the agency minimize 

the burden of the collection of 

information on those who are to 

respond, including through the use of 

appropriate automated, electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology, e.g., permitting 

electronic submission of response. 

Comments that you submit in 

response to this notice are a matter of 

public record. Before including your 

address, phone number, email address, 

or other personal identifying 

information in your comment, you 

should be aware that your entire 

comment—including your personal 

identifying information—may be made 

publicly available at any time. While 

you can ask us in your comment to 

withhold your personal identifying 

information from public review, we 

cannot guarantee that we will be able to 

do so. 

Abstract: Title III of the Indian Trust 

Asset Reform Act (25 U.S.C. 5601, et 

seq.) requires the Secretary of the 

Interior to publish minimum 

qualifications for appraisers of Indian 

property and allows the Secretary to 

accept appraisals performed by those 

appraisers without further review or 

approval. The Secretary developed a 

regulation at 43 CFR part 100 to 

implement these provisions. The 

regulation requires appraisers to submit 

certain information so that the Secretary 

can verify that the appraiser meets the 

minimum qualifications. 

Title of Collection: Appraisals and 

Valuations of Indian Property, 43 CFR 

part 100. 

OMB Control Number: 1076–0188. 

Form Number: None. 

Type of Review: Extension of a 

currently approved collection. 

Respondents/Affected Public: 

Individual Indians and federally 

recognized Indian Tribes seeking 

acquisition of land into trust status. 

Total Estimated Number of Annual 

Respondents: 379. 

Total Estimated Number of Annual 

Responses: 1,137. 

Estimated Completion Time per 

Response: One hour. 

Total Estimated Number of Annual 

Burden Hours: 1,137. 

Respondent’s Obligation: Required to 

Obtain a Benefit. 

Frequency of Collection: On occasion. 

Total Estimated Annual Nonhour 

Burden Cost: $0. 

An agency may not conduct or 

sponsor and a person is not required to 

respond to a collection of information 

unless it displays a currently valid OMB 

control number. 

The authority for this action is the 

Paperwork Reduction Act of 1995 (44 

U.S.C. 3501 et seq.). 

Steven Mullen, 

Information Collection Clearance Officer, 

Office of Regulatory Affairs and Collaborative 

Action—Indian Affairs. 

[FR Doc. 2024–02511 Filed 2–6–24; 8:45 am] 

BILLING CODE 4337–15–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation Nos. 701–TA–489 and 731– 

TA–1201 (Second Review)] 

Drawn Stainless Steel Sinks From 

China 

Determinations 

On the basis of the record 1 developed 

in the subject five-year reviews, the 

United States International Trade 

Commission (‘‘Commission’’) 

determines, pursuant to the Tariff Act of 

1930 (‘‘the Act’’), that revocation of the 

countervailing duty order on drawn 

stainless steel sinks from China and the 

antidumping duty order on drawn 

stainless steel sinks from China would 

be likely to lead to continuation or 

recurrence of material injury to an 

industry in the United States within a 

reasonably foreseeable time. 

Background 

The Commission instituted these 

reviews on July 3, 2023 (88 FR 42688) 

and determined on October 6, 2023 that 

it would conduct expedited reviews (88 

FR 80762, November 20, 2023). 

The Commission made these 

determinations pursuant to section 

751(c) of the Act (19 U.S.C. 1675(c)). It 

completed and filed its determinations 

in these reviews on February 1, 2024. 

The views of the Commission are 

contained in USITC Publication 5489 

(February 2024), entitled Drawn 

Stainless Steel Sinks from China: 

Investigation Nos. 701–TA–489 and 

731–TA–1201 (Second Review). 

By order of the Commission. 

Issued: February 2, 2024. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2024–02458 Filed 2–6–24; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 701–TA–686 (Final)] 

Brass Rod From India 

Determination 

On the basis of the record 1 developed 

in the subject investigation, the United 

States International Trade Commission 

(‘‘Commission’’) determines, pursuant 

to the Tariff Act of 1930 (‘‘the Act’’), 

that an industry in the United States is 

materially injured by reason of imports 

of brass rod from India, provided for in 

subheadings 7407.21.15, 7407.21.30, 

7407.21.70, and 7407.21.90 of the 

Harmonized Tariff Schedule of the 

United States, that have been found by 

the U.S. Department of Commerce 

(‘‘Commerce’’) to be subsidized by the 

government of India.2 3

Background 

The Commission instituted this 

investigation effective April 27, 2023, 

following receipt of a petitions filed 

with the Commission and Commerce by 

the American Brass Rod Fair Trade 

Coalition, Washington, District of 

Columbia; Mueller Brass Co., Port 

Huron, Michigan; and Wieland Chase 

LLC, Montpelier, Ohio. The 

Commission scheduled the final phase 

of the investigation following 

notification of a preliminary 

determination by Commerce that 

imports of brass rod from India were 

being subsidized within the meaning of 

section 703(b) of the Act (19 U.S.C. 

1671b(b)). Notice of the scheduling of 

the final phase of the Commission’s 

investigation and of a public hearing to 

be held in connection therewith was 

given by posting copies of the notice in 

the Office of the Secretary, U.S. 

International Trade Commission, 

Washington, DC, and by publishing the 

notice in the Federal Register of 

October 5, 2023 (88 FR 69229). The 

Commission conducted its hearing on 

December 12, 2023. All persons who 

requested the opportunity were 

permitted to participate. 

The Commission made this 

determination pursuant to § 705(b) of 

the Act (19 U.S.C. 1671d(b)). It 

completed and filed its determination in 

this investigation on February 1, 2024. 

The views of the Commission are 

contained in USITC Publication 5485 

(February 2024), entitled Brass Rod 


khammond on DSKJM1Z7X2PROD with NOTICES